Characteristic | n (%) |
---|---|
Sex | |
 Male | 480 (97) |
 Female | 16 (3) |
Age, years | |
 15–24 | 201 (40) |
 25–34 | 173 (35) |
 ≥35 | 122 (25) |
Weight at treatment initiation (Kg) | |
 <50 | 221 (45) |
 ≥50 | 275 (55) |
Form of TB | |
 PTB+ | 123 (25) |
 PTB− | 150 (30) |
 EPTB | 211 (43) |
 EPTB & PTB | 12 (2) |
Treatment category | |
 New case | 481 (97) |
 Retreatment case | 15 (3) |
HIV status | |
 Negative | 424 (85) |
 Positive | 54 (11) |
 Unknown | 18 (4) |
Antiretroviral treatment (ART)a | |
 On ART at time/within in 3 months of TB treatment | 46 (85) |
 Not on ART | 3 (6) |
 Unknown | 5 (9) |
Use of co-trimoxazole prophylaxisa | |
 On co-trimoxazole at time/within 3 months of TB treatment | 40 (74) |
 Not on co-trimoxazole | 14 (26) |
Site | |
 Alamata | 73 (14) |
 Humera | 163 (33) |
 Mekelle | 183 (37) |
 Shire | 77 (16) |